Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2009

Jun 22, 2009

33090_dirs_2009-06-22_ae365675-5fb4-4c6b-acff-261178819222.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2008-04-30

Reporting Person: Harrell David (Director, Chairman of the Board, 10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3512250 Direct